Emergent BioSolutions Inc header image

Emergent BioSolutions Inc

EBS

Equity

ISIN null / Valor 2672924

New York Stock Exchange, Inc (2025-11-21)
USD 10.04+10.6%

Emergent BioSolutions Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Emergent BioSolutions Inc is a company that specializes in developing, manufacturing, and stockpiling medical countermeasures for military and civilian populations to combat public health threats. They offer drug substance and drug product development and manufacturing services to biopharma innovators, government, and non-government organizations. Their focus is on protecting communities and addressing global health challenges, such as combatting the opioid epidemic with products like NARCAN® Nasal Spray and delivering vaccines and therapeutics.

Summarized from source with an LLMView SourceSector:

Latest Results ():

Summarized from source with an LLMView Source

Key figures

6.81%1Y
-15.2%3Y
-87.9%5Y

Performance

89.4%1Y
111%3Y
97.4%5Y

Volatility

Market cap

527 M

Market cap (USD)

Daily traded volume (Shares)

1,129,143

Daily traded volume (Shares)

1 day high/low

9.4 / 8.28

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00